We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Fitbit (FIT) Rides on Innovation, Rising Competition a Woe
Read MoreHide Full Article
On Jul 12, we issued an updated research report on Fitbit Inc. .
While we are encouraged by the company’s efforts to shift its focus toward healthcare and fitness on diversification of product portfolio, increasing competition and lack of upgrades among existing users raise concerns.
Growth Drivers
The company has been introducing new products to increase revenue base. Yet, these products are unable to drive enough revenues for the company. However, its efforts to further diversify business, and focus on health and wellness could help the company drive revenues in the near future. Just recently, it came up with its first wearable for children, namely Fitbit Ace. This device is aimed at children of eight years and older.
Technology firm Fitbit is undertaking other initiatives that are expected to pull out the company from slow growth. These steps include offering a streamlined set of products, improving software and services to offer more personalization to customers, and achieving greater integration into the healthcare ecosystem.
Positive Earnings Surprise History: Fitbit has an impressive earnings surprise history. The company outpaced the Zacks Consensus Estimate in three of the trailing four quarters, delivering an average positive earnings surprise of 42.78%.
Headwinds
Notably, Fitbit has underperformed the industry over the past year. Shares of the company have gained 16.9% compared with the industry’s growth of nearly 39.2%.
Fitbit, which became a prominent name for simple fitness wearables, has been hurt by massive competition in the market. It faces competition in both the high and low-end product range. On the high-end front, it competes with Apple Watch. Although Fitbit expected Ionic to help the company take on Apple, it is hardly an easy task to compete with one of the biggest companies in the world. On the lower end, fitness-tracking devices from Jawbone, Garmin Ltd. (GRMN) and Xiaomi also pose tough competition.
Currently, Fitbit carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the same industry include Groupon (GRPN - Free Report) , IAC/InterActiveCorp (IAC - Free Report) and Ctrip.com International, Ltd. . While Groupon and IAC/InterActiveCorp sport a Zacks Rank #1 (Strong Buy), Ctrip.com holds a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Long-term earnings growth for Groupon, IAC/InterActiveCorp and Ctrip.com is currently projected to be 6.5%, 7.5% and 16%, respectively.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Fitbit (FIT) Rides on Innovation, Rising Competition a Woe
On Jul 12, we issued an updated research report on Fitbit Inc. .
While we are encouraged by the company’s efforts to shift its focus toward healthcare and fitness on diversification of product portfolio, increasing competition and lack of upgrades among existing users raise concerns.
Growth Drivers
The company has been introducing new products to increase revenue base. Yet, these products are unable to drive enough revenues for the company. However, its efforts to further diversify business, and focus on health and wellness could help the company drive revenues in the near future. Just recently, it came up with its first wearable for children, namely Fitbit Ace. This device is aimed at children of eight years and older.
Technology firm Fitbit is undertaking other initiatives that are expected to pull out the company from slow growth. These steps include offering a streamlined set of products, improving software and services to offer more personalization to customers, and achieving greater integration into the healthcare ecosystem.
Positive Earnings Surprise History: Fitbit has an impressive earnings surprise history. The company outpaced the Zacks Consensus Estimate in three of the trailing four quarters, delivering an average positive earnings surprise of 42.78%.
Headwinds
Notably, Fitbit has underperformed the industry over the past year. Shares of the company have gained 16.9% compared with the industry’s growth of nearly 39.2%.
Fitbit, which became a prominent name for simple fitness wearables, has been hurt by massive competition in the market. It faces competition in both the high and low-end product range. On the high-end front, it competes with Apple Watch. Although Fitbit expected Ionic to help the company take on Apple, it is hardly an easy task to compete with one of the biggest companies in the world. On the lower end, fitness-tracking devices from Jawbone, Garmin Ltd. (GRMN) and Xiaomi also pose tough competition.
Fitbit, Inc. Price and Consensus
Fitbit, Inc. Price and Consensus | Fitbit, Inc. Quote
Zacks Rank & Stocks to Consider
Currently, Fitbit carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the same industry include Groupon (GRPN - Free Report) , IAC/InterActiveCorp (IAC - Free Report) and Ctrip.com International, Ltd. . While Groupon and IAC/InterActiveCorp sport a Zacks Rank #1 (Strong Buy), Ctrip.com holds a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Long-term earnings growth for Groupon, IAC/InterActiveCorp and Ctrip.com is currently projected to be 6.5%, 7.5% and 16%, respectively.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>